This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

EARLY SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
7-9 March 2023
Westin Miyako KyotoKyoto, Japan

7-9 March 2023
Westin Miyako Kyoto,
Kyoto, Japan

Leverage TIDES Asia to engage the oligonucleotide and peptide community in Asia!

This event series will continue to provide cutting-edge content to the TIDES scientific community in Asia, by covering the latest developments in oligonucleotide, peptide, mRNA and genome editing therapeutic discovery, CMC/ manufacturing and delivery. Offer content to raise your profile and reinforce your thought leadership status – all while generating highly qualified leads!

Additional Lead Generation Opportunities

On-Demand Presentation

Choose between a 10 minute or 20 minute on-demand presentation. Attendees will have access to the presentation during the event as well as post-event. Your will capture the contact details of who views your asset during the week of the event.

Scientific Poster Presentation

Provide a scientific poster presentation for download by attendees. Promote your latest research while gathering some lead generation for your company.

Custom Email

Provide us with HTML copy tailored completed by you that we’ll send to all attendees pre or post event

Audience Extension

Attendee targeting that serves your ad to decision makers within our database who match your exact custom criteria. Utilizing thousands of news-safe websites across the web, your campaign is displayed multiple times ONLY to those that fit your targeted profile.

e-Books

Include some of your content in your own chapter in one of our electronic books around TIDES Asia. This content can be gated, generating you targeted lead generation.